For example, rosiglitazone can alleviate APAP-induced ALI by down-regulating protein levels of p-PERK, p-eIF2α and CHOP in the PERK pathway and attenuating ER stress (Cao et al., 2022). This evidence concerns the gene EIF2A and acute respiratory distress syndrome.